Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
2.01 Down 0.03(1.47%) 4:00PM EDT
Prev Close:2.04
Open:2.01
Bid:1.80 x 100
Ask:2.30 x 100
1y Target Est:3.50
Beta:0.85
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:1.99 - 2.10
52wk Range:1.53 - 4.91
Volume:44,199
Avg Vol (3m):100,003
Market Cap:24.08M
P/E (ttm):N/A
EPS (ttm):-1.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECTE

Comparison

Symbol% ChgMkt Cap
ECTEDown 1.47%24.08M
ABTDown 0.28%64.54B
DXCMUp 1.77%2.88B
MDTUp 1.05%63.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,011.89
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Jun-14) :-0.23
Mean Recommendation*:3.7
PEG Ratio (5 yr expected):-0.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback